Regulatory B cells producing IL-10 are increased in human tumor draining lymph nodes.

Autor: Piersiala K; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Hjalmarsson E; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., da Silva PFN; Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden., Lagebro V; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Kolev A; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.; Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Starkhammar M; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Elliot A; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.; Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Marklund L; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.; Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden., Munck-Wikland E; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.; Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Margolin G; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.; Medical unit Head Neck, Lung and skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Georén SK; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Aug 15; Vol. 153 (4), pp. 854-866. Date of Electronic Publication: 2023 May 05.

A Novel Sentinel Lymph Node Approach in Oral Squamous Cell Carcinoma.

Autor: Kågedal Å; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Margolin G; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Held C; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., da Silva PFN; Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden., Piersiala K; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Munck-Wikland E; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Jacobsson H; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Häyry V; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: Current pharmaceutical design [Curr Pharm Des] 2020; Vol. 26 (31), pp. 3834-3839.